These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 12566301)
1. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301 [TBL] [Abstract][Full Text] [Related]
2. Protein A-induced apoptosis of cancer cells is effected by soluble immune mediators. Das T; Sa G; Chattopadhyay S; Ray PK Cancer Immunol Immunother; 2002 Sep; 51(7):376-80. PubMed ID: 12192537 [TBL] [Abstract][Full Text] [Related]
3. Potent anti-proliferative, pro-apoptotic activity of the Maytenus royleanus extract against prostate cancer cells: evidence in in-vitro and in-vivo models. Shabbir M; Syed DN; Lall RK; Khan MR; Mukhtar H PLoS One; 2015; 10(3):e0119859. PubMed ID: 25798940 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation. Zhu D; Corral LG; Fleming YW; Stein B Cancer Immunol Immunother; 2008 Dec; 57(12):1849-59. PubMed ID: 18392823 [TBL] [Abstract][Full Text] [Related]
5. A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer. Ohnmacht SA; Marchetti C; Gunaratnam M; Besser RJ; Haider SM; Di Vita G; Lowe HL; Mellinas-Gomez M; Diocou S; Robson M; Šponer J; Islam B; Pedley RB; Hartley JA; Neidle S Sci Rep; 2015 Jun; 5():11385. PubMed ID: 26077929 [TBL] [Abstract][Full Text] [Related]
6. Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model. Fernandez-Cabezudo MJ; El-Kharrag R; Torab F; Bashir G; George JA; El-Taji H; al-Ramadi BK PLoS One; 2013; 8(2):e55993. PubMed ID: 23409104 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis pathways in cancer and cancer therapy. Debatin KM Cancer Immunol Immunother; 2004 Mar; 53(3):153-9. PubMed ID: 14749900 [TBL] [Abstract][Full Text] [Related]
8. Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting Strategies. Mirzayans R Curr Issues Mol Biol; 2024 May; 46(6):5379-5396. PubMed ID: 38920994 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF. Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system. Calvillo-Rodríguez KM; Lorenzo-Anota HY; Rodríguez-Padilla C; Martínez-Torres AC; Scott-Algara D Front Immunol; 2023; 14():1294434. PubMed ID: 38077402 [TBL] [Abstract][Full Text] [Related]
11. A Novel Nanoemulsion Formula for an Improved Delivery of a Thalidomide Analogue to Triple-Negative Breast Cancer; Synthesis, Formulation, Characterization and Molecular Studies. Tawfik NM; Teiama MS; Iskandar SS; Osman A; Hammad SF Int J Nanomedicine; 2023; 18():1219-1243. PubMed ID: 36937550 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer. Chen LX; Ni XL; Zhang H; Wu M; Liu J; Xu S; Yang LL; Fu SZ; Wu J Int J Nanomedicine; 2018; 13():2463-2476. PubMed ID: 29719394 [TBL] [Abstract][Full Text] [Related]
13. Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells. Zhang X; Luo H Oncol Lett; 2018 Mar; 15(3):3313-3320. PubMed ID: 29435073 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis. Liu X; Wang H; Wu X; Hong X; Luo Z Invest New Drugs; 2018 Feb; 36(1):114-120. PubMed ID: 29170886 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide. Liu Q; Yin T; Wang G; Guo F; Ou Y; Li Y; Wang Y Exp Ther Med; 2017 Nov; 14(5):4263-4271. PubMed ID: 29075340 [TBL] [Abstract][Full Text] [Related]
16. Effect of thalidomide in combination with gemcitabine on human pancreatic carcinoma SW-1990 cell lines Qiao Z; Yuan J; Shen J; Wang C; He Z; Hu Y; Zhang M; Xu C Oncol Lett; 2015 May; 9(5):2353-2360. PubMed ID: 26137070 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 (MMP-1) expression in rat spinal cord injury model. Zhou Y; Cui Z; Xia X; Liu C; Zhu X; Cao J; Wu Y; Zhou L; Ben Z; Song Y; Zhang H; Zhang D Cell Mol Neurobiol; 2014 Nov; 34(8):1151-63. PubMed ID: 25073870 [TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal pattern of TRAF3 expression after rat spinal cord injury. Wu Y; Zheng M; Wang S; Song C; Wang C; Xiao Y; Xu L; Xu X J Mol Histol; 2014 Oct; 45(5):541-53. PubMed ID: 24803166 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Chang X; Zhu Y; Shi C; Stewart AK Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):240-53. PubMed ID: 24374776 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide-a notorious sedative to a wonder anticancer drug. Zhou S; Wang F; Hsieh TC; Wu JM; Wu E Curr Med Chem; 2013; 20(33):4102-8. PubMed ID: 23931282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]